- Home
- AAMI vs INSP Comparison
AAMI vs INSP Comparison
Compare AAMI & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAMI | INSP |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AAMI | INSP |
|---|---|---|
| Price | $92.81 | $65.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $58.00 | ★ $94.00 |
| AVG Volume (30 Days) | 298.0K | ★ 393.0K |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.61% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $426,600,000.00 | $82,050,000.00 |
| Revenue This Year | $32.73 | $8.02 |
| Revenue Next Year | $14.44 | $8.11 |
| P/E Ratio | $63.99 | ★ N/A |
| Revenue Growth | 2.25 | ★ 62.18 |
| 52 Week Low | $41.47 | $38.91 |
| 52 Week High | $98.52 | $147.03 |
Technical Indicators
Market Signals| Indicator | AAMI | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 55.87 | 66.15 |
| Support Level | $90.16 | $56.50 |
| Resistance Level | $93.82 | $66.21 |
| Average True Range (ATR) | 2.64 | 2.75 |
| MACD | -0.55 | -0.07 |
| Stochastic Oscillator | 41.36 | 77.44 |
Price Performance
Historical ComparisonAbout AAMI Acadian Asset Management Inc.
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.